IDM Asset Delivery Process Engineer at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Medical Devices, HealthcareIndustries

Requirements

(Details missing)

Responsibilities

Assess technical proposals from original equipment manufacturers (OEMs)
Generate user requirements for each project asset
Manage PFMEA development to identify and mitigate technical and patient risks
Conduct detailed design reviews with OEMs and project teams to ensure design aligns with all requirements and conforms to local/corporate standards
Verify OEM design documentation is comprehensive, complete, and accurately represents the specifications of the equipment
Establish key control parameters through the Engineering Studies Plan
Develop and implement engineering studies protocols and summarized reports for verification testing
Identify opportunities to optimize equipment performance
Assess, document safety risks, and engage in HSE walkdowns
Work with OEM and local site to develop the maintenance plan
Utilize engineering tools such as Design of Experiments (DOE), Gauge Repeatability & Reproducibility (GR&R), and statistical methods for conducting engineering studies and preparing reports
Change Management (Details missing)

Skills

PFMEA

DOE

GR&R

Design Reviews

User Requirements

Engineering Studies

Statistical Methods

Risk Assessment

HSE Walkdowns

Maintenance Planning

Design Verification

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free